Bausch Health Announces Participation In Upcoming Investor Conferences

Rhea-AI Summary

Bausch Health Companies Inc. (NYSE/TSX: BHC) announced its participation in investor conferences, including the Goldman Sachs Leveraged Finance and Credit Conference on May 12, 2022, and the Barclays High Yield Bond & Syndicated Loan Conference on May 24, 2022. Key executives such as Tom Vadaketh and Christina Cheng will represent the company. Live webcasts of these events will be accessible on the Investor Relations page of their website. Bausch Health focuses on enhancing global health through a diverse range of pharmaceutical products.

LAVAL, QC, May 11, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in several upcoming investor conferences.

Tom Vadaketh, executive vice president and chief financial officer; William Woodfield, senior vice president and treasurer; and Christina Cheng, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the 7^th Annual Goldman Sachs Leveraged Finance and Credit Conference in Long Beach, Calif. on May 12, 2022 at 9:05 a.m. PT and at the Barclays High Yield Bond & Syndicated Loan Conference in Austin, Texas on May 24, 2022 at 11:00 a.m. CT.

A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2022.

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our 90% ownership of Bausch + Lomb Corporation. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.

 

Investor Contact:	Media Contact:
Christina Cheng	Lainie Keller
Christina.cheng@bauschhealth.com	lainie.keller@bauschhealth.com
(514) 856-3855	(908) 927-1198
(877) 281-6642 (toll free)

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-announces-participation-in-upcoming-investor-conferences-301544156.html

SOURCE Bausch Health Companies Inc.

FAQ

What events will Bausch Health participate in during May 2022?

Bausch Health will participate in the Goldman Sachs Leveraged Finance and Credit Conference on May 12, 2022, and the Barclays High Yield Bond & Syndicated Loan Conference on May 24, 2022.

Who from Bausch Health will speak at the investor conferences?

Executives including Tom Vadaketh, William Woodfield, and Christina Cheng will represent Bausch Health at the investor conferences.

Where can I watch the Bausch Health investor conference webcasts?

The webcasts of Bausch Health's investor conferences will be available on the Investor Relations page of their website.

When will the Goldman Sachs conference take place?

The Goldman Sachs Leveraged Finance and Credit Conference is scheduled for May 12, 2022, at 9:05 a.m. PT.

When is Bausch Health's participation in the Barclays conference?

Bausch Health will participate in the Barclays High Yield Bond & Syndicated Loan Conference on May 24, 2022, at 11:00 a.m. CT.